Bio-Path released updated Phase 2 data for its lead candidate prexigebersen, codenamed BP1001, for treating acute myeloid leukemia, or AML, and also divulged a plan of action for taking the compound through clinical development toward registration. Updated data from the Stage 1 of the Phase 2 study that evaluated the efficacy and safety of prexigebersen in...
What the fuck do they have? Cure for AML? other L, other Cancer? i dont' know but it's too cheap here!!
This stock BPTH has HIGH volume with breaking previous day highs also with the recent pullback TOP green candle. Looking for a interesting LONG.
really testing the $2 mark technicals look good!
looks like a Cup is forming, had a nice closing today at 1.8 watch out if long downtrendline can be broken volume still too low, needs to increase
10/27 - Begin Watch - Look for good volume to buy the dip @ $.034 or Confirmation buy candle at $0.36 let's see what happens...!!
Plan is to profit a 30% stake on this one. Im in @ 0.65 today. My limit-order is allready place. This is the right time to entre! I will try to hold this one till next MPP GREEN FRIDAY! But sell it today take profit and monday we will see it again. Never Ever hold a stock true weekend. is to risky! Good luck traders!
I really like this one, will catch most of my attention coming days / weeks